Breaking News, Collaborations & Alliances

PharmAbcine, Binex Ink Long-term Contract Manufacturing Deal

CDMO Binex responsible for large-scale manufacturing of clinical investigational material for PharmAbcine for its global Phase 2 trials of olinvacimab.

By: Contract Pharma

Contract Pharma Staff

PharmAbcine, biotech company focusing on the development of antibody therapeutics, has signed a contract manufacturing organization(CMO) agreement with biologics contract development and manufacturing organization (CDMO) Binex for additional production of investigational olinvacimab (TTAC-0001), PharmAbcine’s leading antibody therapeutics pipeline in oncology.   Under the agreement, Binex is responsible for large-scale manufacturing of clinical investigational material for PharmAbcine for ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters